Is Agios Pharmaceuticals, Inc. (AGIO) a Buy, Sell, or Hold?
NASDAQ : AGIO
Agios Pharmaceuticals, Inc. — Institutional Ownership
$35.99 USD
-$0.98 (-2.65%)
- Volume
- 802.34K
- Average Volume
- 1.08M
- Market Capitalization
- $2.14B
- P/E Ratio
- -4.96
- Dividend Yield
- 0.00%
- Price Target
- $41.00
- Year High
- $46.00
- Year Low
- $22.24
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.19
Institutional Ownership Summary
Institutional Ownership %
0.50%
Investors Holding
31
change: -216 | last: 247
Increased Positions
17
change: -106 | last: 123
Reduced Positions
6
change: -70 | last: 76
New Positions
5
change: -31 | last: 36
Sold Positions
208
change: 167 | last: 41
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -10.7739 | last: 0.1077
Total Invested
10.9M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-02 | D. E. Shaw & Co., L.P. | 3.03M | 5.10% |
| 2026-05-15 | Armistice Capital, LLC | 2.72M | 4.57% |
| 2026-05-06 | Lynx1 Capital Management LP | 3.01M | 5.10% |
| 2026-04-29 | Vanguard Capital Management | 3.09M | 5.27% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Armistice Capital, LLC | 3.04M | 5.21% |
| 2026-02-09 | Farallon Capital Partners, L.P. | 413.36K | 0.70% |
| 2026-02-09 | STATE STREET CORPORATION | 3.11M | 5.30% |
| 2025-12-05 | Bellevue Group AG | - | 0.00% |
| 2025-11-14 | Paradigm BioCapital Advisors LP | 2.87M | 4.90% |
| 2025-08-28 | Paradigm BioCapital Advisors LP | 3.03M | 5.20% |
| 2025-07-17 | BlackRock, Inc. | 4.51M | 7.80% |
| 2025-07-07 | Bellevue Group AG | 3.52M | 6.10% |
| 2025-06-13 | BB Biotech AG | - | 0.00% |
| 2025-02-14 | BB Biotech AG | 3.52M | 6.20% |
| 2025-02-04 | Farallon Capital Partners, L.P. | 422.48K | 0.70% |
| 2023-11-09 | Farallon F5 (GP), L.L.C. | 172.06K | 0.30% |
| 2023-11-09 | Farallon Healthcare Partners (GP), L.L.C. | 2.01M | 3.60% |
| 2023-11-09 | Richard B. Fried | 3.96M | 7.10% |
| 2023-11-09 | William Seybold | 3.96M | 7.10% |
| 2023-11-09 | Daniel S. Short | 3.96M | 7.10% |
| 2023-11-09 | John R. Warren | 3.96M | 7.10% |
| 2023-11-09 | Mark C. Wehrly | 3.96M | 7.10% |
| 2023-11-09 | Rajiv A. Patel | 3.96M | 7.10% |
| 2023-11-09 | Farallon Capital (AM) Investors, L.P. | 52787.0 | 0.10% |
| 2023-11-09 | Farallon Capital Offshore Investors II, L.P. | 700.3K | 1.30% |
| 2023-11-09 | Four Crossings Institutional Partners V, L.P. | 85481.0 | 0.20% |
| 2023-11-09 | Farallon Capital Institutional Partners III, L.P. | 50807.0 | 0.10% |
| 2023-11-09 | Farallon Capital Institutional Partners II, L.P. | 125.01K | 0.20% |
| 2023-11-09 | Farallon Capital Offshore Investors II, L.P. | 700.3K | 1.30% |
| 2023-11-09 | Farallon Capital Institutional Partners II, L.P. | 125.01K | 0.20% |
| 2023-11-09 | Farallon Capital Institutional Partners, L.P. | 428.25K | 0.80% |
| 2023-11-09 | Farallon Capital Partners, L.P. | 332.37K | 0.60% |
| 2023-11-09 | Four Crossings Institutional Partners V, L.P. | 85481.0 | 0.20% |
| 2023-11-09 | Philip D. Dreyfuss | 3.96M | 7.10% |
| 2023-11-09 | David T. Kim | 3.96M | 7.10% |
| 2023-11-09 | William Seybold | 3.96M | 7.10% |
| 2023-11-09 | Daniel S. Short | 3.96M | 7.10% |
| 2023-11-09 | Farallon Capital Institutional Partners III, L.P. | 50807.0 | 0.10% |
| 2023-11-09 | Michael G. Linn | 3.96M | 7.10% |
| 2023-11-09 | Rajiv A. Patel | 3.96M | 7.10% |
| 2023-11-09 | Thomas G. Roberts, Jr. | 3.96M | 7.10% |
| 2023-11-09 | Edric C. Saito | 3.96M | 7.10% |
| 2023-11-09 | Farallon Capital Partners, L.P. | 332.37K | 0.60% |
| 2023-11-09 | Farallon Capital Institutional Partners, L.P. | 428.25K | 0.80% |
| 2023-11-09 | Farallon Capital (AM) Investors, L.P. | 52787.0 | 0.10% |
| 2023-11-09 | Farallon Capital F5 Master I, L.P. | 172.06K | 0.30% |
| 2023-11-09 | Farallon Healthcare Partners Master, L.P. | 2.01M | 3.60% |
| 2023-11-09 | Farallon Partners, L.L.C. | 3.79M | 6.80% |
| 2023-11-09 | Farallon Institutional (GP) V, L.L.C. | 85481.0 | 0.20% |
| 2023-11-09 | Joshua J. Dapice | 3.96M | 7.10% |
| 2023-11-09 | Philip D. Dreyfuss | 3.96M | 7.10% |
| 2023-11-09 | Hannah E. Dunn | 3.96M | 7.10% |
| 2023-11-09 | Farallon Capital F5 Master I, L.P. | 172.06K | 0.30% |
| 2023-11-09 | Farallon Healthcare Partners Master, L.P. | 2.01M | 3.60% |
| 2023-11-09 | Andrew J. M. Spokes | 3.96M | 7.10% |
| 2023-11-09 | Farallon F5 (GP), L.L.C. | 172.06K | 0.30% |
| 2023-11-09 | Farallon Healthcare Partners (GP), L.L.C. | 2.01M | 3.60% |
| 2023-11-09 | Varun N. Gehani | 3.96M | 7.10% |
| 2023-11-09 | Hannah E. Dunn | 3.96M | 7.10% |
| 2023-11-09 | Richard B. Fried | 3.96M | 7.10% |
| 2023-11-09 | Nicolas Giauque | 3.96M | 7.10% |
| 2023-11-09 | Michael G. Linn | 3.96M | 7.10% |
| 2023-11-09 | Thomas G. Roberts, Jr. | 3.96M | 7.10% |
| 2023-11-09 | Edric C. Saito | 3.96M | 7.10% |
| 2023-11-09 | Andrew J. M. Spokes | 3.96M | 7.10% |
| 2023-11-09 | John R. Warren | 3.96M | 7.10% |
| 2023-11-09 | Mark C. Wehrly | 3.96M | 7.10% |
| 2023-11-09 | Farallon Partners, L.L.C. | 3.79M | 6.80% |
| 2023-11-09 | Farallon Institutional (GP) V, L.L.C. | 85481.0 | 0.20% |
| 2023-11-09 | Joshua J. Dapice | 3.96M | 7.10% |
| 2023-11-09 | Varun N. Gehani | 3.96M | 7.10% |
| 2023-11-09 | Nicolas Giauque | 3.96M | 7.10% |
| 2023-11-09 | David T. Kim | 3.96M | 7.10% |
| 2023-02-14 | Steven Boyd | 2.75M | 5.01% |
| 2023-02-14 | Rock Springs Capital Management LP | 3M | 5.45% |
| 2023-02-14 | Rock Springs Capital LLC | 3M | 5.45% |
| 2023-02-14 | Armistice Capital, LLC | 2.75M | 5.01% |
| 2023-02-14 | Steven Boyd | 2.75M | 5.01% |
| 2023-02-14 | Armistice Capital, LLC | 2.75M | 5.01% |
| 2023-02-14 | Rock Springs Capital Management LP | 3M | 5.45% |
| 2023-02-14 | Rock Springs Capital LLC | 3M | 5.45% |
| 2022-10-06 | JPMORGAN CHASE & CO.13-2624428 | 1.49M | 2.70% |
| 2022-09-12 | FMR LLC | 2.01M | 3.66% |
| 2022-09-12 | Abigail P. Johnson | 2.01M | 3.66% |
| 2022-03-09 | (1) BlackRock, Inc. | 5.5M | 10.10% |
| 2022-02-14 | 52-0556948 | 2.88M | 5.30% |
| 2022-02-14 | 52-0556948 | 2.88M | 5.30% |
| 2022-02-11 | BB Biotech AG | 4.31M | 7.90% |
| 2022-02-11 | BB Biotech AG | 4.31M | 7.90% |
| 2022-02-11 | N.V. | 4.31M | 7.90% |
| 2022-02-11 | N.V. | 4.31M | 7.90% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 5.07M | 9.33% |
| 2022-02-09 | STATE STREET CORPORATION | 2.99M | 5.51% |
| 2022-02-04 | Wellington Management Group LLP | 5.15M | 9.48% |
| 2022-02-04 | Wellington Management Company LLP | 5.15M | 9.48% |
| 2022-02-04 | Wellington Investment Advisors Holdings LLP | 5.15M | 9.48% |
| 2022-02-04 | Wellington Group Holdings LLP | 5.15M | 9.48% |
| 2022-02-04 | Wellington Investment Advisors Holdings LLP | 5.15M | 9.48% |
| 2022-02-04 | Wellington Management Group LLP | 5.15M | 9.48% |
| 2022-02-04 | Wellington Group Holdings LLP | 5.15M | 9.48% |
| 2022-02-04 | Wellington Management Company LLP | 5.15M | 9.48% |
| 2022-02-03 | (1) BlackRock, Inc. | 5.41M | 9.95% |
| 2022-01-19 | JPMORGAN CHASE & CO.13-2624428 | 3.1M | 5.70% |
| 2021-12-09 | The Vanguard Group - 23-1945930 | 5.48M | 10.10% |
| 2021-08-09 | (1) BlackRock, Inc. | 5.93M | 10.10% |
| 2021-02-12 | Biotech Target N.V. | 4.16M | 6.00% |
| 2021-02-12 | Biotech Target N.V. | 4.16M | 6.00% |
| 2021-02-12 | BB Biotech AG | 4.16M | 6.00% |
| 2021-02-12 | BB Biotech AG | 4.16M | 6.00% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 5.63M | 8.12% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 5.63M | 8.12% |
| 2021-02-03 | Wellington Management Group LLP | 7.88M | 11.37% |
| 2021-01-29 | (1) BlackRock, Inc. | 4.48M | 6.50% |
| 2020-11-10 | 95-1411037 | 13.0 | 0.30% |
| 2020-02-14 | 2. | 3.9M | 12.00% |
| 2020-02-14 | 2. | 3.9M | 12.00% |
| 2020-02-14 | Capital International Investors ** | 4.65M | 6.90% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 5.61M | 8.20% |
| 2020-02-12 | VANGUARD SPECIALIZED FUNDS - VANGUARD HEALTH CARE FUND - 23-2439149 | - | 0.00% |
| 2020-02-07 | (1) BlackRock, Inc. | 3.89M | 5.80% |
| 2020-01-08 | Wellington Management Company LLP | 7.89M | 11.54% |
| 2020-01-08 | Wellington Group Holdings LLP | 7.98M | 11.67% |
| 2020-01-08 | Wellington Management Group LLP | 7.98M | 11.67% |
| 2020-01-08 | Wellington Investment Advisors Holdings LLP | 7.98M | 11.67% |
| 2019-11-14 | CELGENE EUROPEAN INVESTMENT COMPANY LLC | 4.01M | 6.00% |
| 2019-11-14 | CELGENE SWITZERLAND LLC | 624.58K | 0.90% |
| 2019-11-14 | CELGENE ALPINE INVESTMENT CO., LLC | 708.33K | 1.10% |
| 2019-11-14 | CELGENE CORPORATION | 7.12M | 10.60% |
| 2019-10-09 | (1) BlackRock, Inc. | 2.91M | 4.96% |
| 2019-02-12 | Wellington Management Company LLP | 8.04M | 13.82% |
| 2019-02-12 | Wellington Management Group LLP | 8.14M | 14.00% |
| 2019-02-12 | Wellington Group Holdings LLP | 8.14M | 14.00% |
| 2019-02-12 | Wellington Investment Advisors Holdings LLP | 8.14M | 14.00% |
| 2019-02-04 | (1) BlackRock, Inc. | 3.32M | 5.70% |
| 2019-01-28 | 10. | 2.98M | 5.12% |
| 2018-02-08 | Wellington Group Holdings LLP | 6.83M | 14.00% |
| 2018-02-08 | Wellington Management Group LLP | 6.83M | 14.00% |
| 2018-02-08 | Wellington Investment Advisors Holdings LLP | 6.83M | 14.00% |
| 2018-02-08 | Wellington Management Company LLP | 6.69M | 13.73% |
| 2018-02-01 | (1) BlackRock, Inc. | 2.81M | 5.80% |
| 2017-05-09 | (1) BlackRock, Inc. | 2.28M | 4.80% |
| 2017-02-09 | Wellington Management Group LLP | 5.88M | 14.00% |
| 2017-02-09 | Wellington Group Holdings LLP | 5.88M | 14.00% |
| 2017-02-09 | Wellington Management Company LLP | 5.75M | 13.68% |
| 2017-02-09 | Wellington Group Holdings LLP | 5.88M | 14.00% |
| 2017-02-09 | Wellington Investment Advisors Holdings LLP | 5.88M | 14.00% |
| 2017-02-09 | Wellington Management Group LLP | 5.88M | 14.00% |
| 2017-02-09 | Wellington Management Company LLP | 5.75M | 13.68% |
| 2017-02-09 | Wellington Investment Advisors Holdings LLP | 5.88M | 14.00% |
| 2017-01-30 | (1) BlackRock, Inc. | 2.15M | 5.10% |
| 2017-01-09 | Capital International Investors ** | 4.21M | 10.00% |
| 2016-02-11 | Wellington Management Group LLP | 5.27M | 13.99% |
| 2016-02-11 | Wellington Group Holdings LLP | 5.27M | 13.99% |
| 2016-02-11 | Wellington Investment Advisors Holdings LLP | 5.27M | 13.99% |
| 2016-02-11 | Wellington Management Company LLP | 5.1M | 13.55% |
| 2016-02-09 | VANGUARD SPECIALIZED FUNDS - VANGUARD HEALTH CARE FUND | 2.52M | 6.70% |
| 2016-02-09 | 10. | 2.16M | 5.70% |
| 2016-02-09 | 2. | 2.16M | 5.70% |
| 2015-06-08 | Wellington Management Group LLP | 3.96M | 10.62% |
| 2015-06-08 | Wellington Group Holdings LLP | 3.96M | 10.62% |
| 2015-06-08 | Wellington Investment Advisors Holdings LLP | 3.96M | 10.62% |
| 2015-06-08 | Wellington Management Company LLP | 3.83M | 10.27% |
| 2015-02-13 | Abigail P. Johnson | 5.49M | 15.00% |
| 2015-02-13 | Third Rock Ventures GP, L.P. | 3.07M | 8.40% |
| 2015-02-13 | Third Rock Ventures, L.P. | 3.07M | 8.40% |
| 2015-02-13 | Kevin P. Starr | 3.1M | 8.50% |
| 2015-02-13 | TRV GP, LLC | 3.07M | 8.40% |
| 2015-02-13 | FMR LLC | 5.49M | 15.00% |
| 2015-02-13 | Edward C. Johnson 3d | 5.49M | 15.00% |
| 2015-02-12 | 1,864,921 | 1.86M | 5.10% |
| 2015-02-11 | Robert Nelsen | 3.48M | 9.40% |
| 2015-02-11 | ARCH Venture Partners VII, L.P. | 3.47M | 9.40% |
| 2015-02-11 | ARCH Venture Fund VII, L.P. | 3.47M | 9.40% |
| 2015-02-11 | ARCH Venture Partners VII, LLC | 3.47M | 9.40% |
| 2015-02-11 | Clinton Bybee | 3.48M | 9.40% |
| 2015-02-11 | Keith Crandell | 3.48M | 9.40% |
| 2014-09-11 | 1,745,521 | 1.75M | 5.10% |
| 2014-09-11 | 2. | 1.75M | 5.10% |
| 2014-09-11 | 1,745,521 | 1.75M | 5.10% |
| 2014-09-11 | 2. | 1.75M | 5.10% |
| 2014-02-12 | Third Rock Ventures GP, L.P. | 5.56M | 17.90% |
| 2014-02-12 | Third Rock Ventures, L.P. | 5.56M | 17.90% |
| 2014-02-12 | Kevin P. Starr | 5.56M | 17.90% |
| 2014-02-12 | TRV GP, LLC | 5.56M | 17.90% |
| 2014-02-10 | 10. | 3.86M | 12.40% |
| 2014-02-10 | 2. | 3.86M | 12.40% |
| 2014-02-10 | 10. | 3.86M | 12.40% |
| 2014-02-10 | 2. | 3.86M | 12.40% |
| 2014-02-10 | 2. | 3.86M | 12.40% |
| 2014-02-10 | 2. | 3.86M | 12.40% |
| 2014-02-10 | 2. | 3.86M | 12.40% |
| 2014-02-10 | 2. | 3.86M | 12.40% |
| 2014-02-06 | ARCH Venture Partners VII, L.P. | 3.86M | 12.40% |
| 2014-02-06 | Clinton Bybee | 3.86M | 12.40% |
| 2014-02-06 | Robert Nelsen | 3.86M | 12.40% |
| 2014-02-06 | Clinton Bybee | 3.86M | 12.40% |
| 2014-02-06 | ARCH Venture Fund VII, L.P. | 3.86M | 12.40% |
| 2014-02-06 | Keith Crandell | 3.86M | 12.40% |
| 2014-02-06 | ARCH Venture Partners VII, LLC | 3.86M | 12.40% |
| 2014-02-06 | ARCH Venture Partners VII, L.P. | 3.86M | 12.40% |
| 2014-02-06 | ARCH Venture Fund VII, L.P. | 3.86M | 12.40% |
| 2014-02-06 | Robert Nelsen | 3.86M | 12.40% |
| 2014-02-06 | Keith Crandell | 3.86M | 12.40% |
| 2014-02-06 | ARCH Venture Partners VII, LLC | 3.86M | 12.40% |
| 2013-11-12 | Edward C. Johnson 3d | 4.5M | 14.49% |
| 2013-11-12 | FMR LLC | 4.5M | 14.49% |
AGIO Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $27.22 | 57.97M | $1.58B | $89.13M | $62.02M | $1.55B |
| 2024-12-31 | $32.86 | 56.81M | $1.87B | $76.25M | $56.99M | $1.85B |
| 2023-12-31 | $22.27 | 55.65M | $1.24B | $88.2M | $72M | $1.22B |
| 2022-12-31 | $28.08 | 54.79M | $1.54B | $139.26M | $85.66M | $1.48B |
| 2021-12-31 | $32.87 | 60.45M | $1.99B | $203.13M | $97.09M | $1.88B |
| 2020-12-31 | $43.33 | 69M | $2.99B | $127.44M | $105.2M | $2.97B |
| 2019-12-31 | $47.75 | 59.99M | $2.86B | $80.93M | $113.66M | $2.9B |
| 2018-12-31 | $46.11 | 57.42M | $2.65B | $805.42M | -$ | $1.84B |
| 2017-12-31 | $57.17 | 46.59M | $2.66B | $567.75M | -$ | $2.1B |
| 2016-12-31 | $41.73 | 39.13M | $1.63B | $573.56M | -$ | $1.06B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33.83 | 58.78M | $1.99B | $113.6M | $35.74M | $1.91B |
| 2025-12-31 | $27.22 | 58.33M | $1.59B | $89.13M | $40.21M | $1.54B |
| 2025-09-30 | $40.14 | 58.14M | $2.33B | $92.71M | $44.52M | $2.29B |
| 2025-06-30 | $33.26 | 57.93M | $1.93B | $80.87M | $48.76M | $1.89B |
| 2025-03-31 | $29.30 | 57.46M | $1.68B | $78.96M | $52.94M | $1.66B |
| 2024-12-31 | $32.86 | 57.16M | $1.88B | $76.25M | $56.99M | $1.86B |
| 2024-09-30 | $44.43 | 56.94M | $2.53B | $253.73M | $60.83M | $2.34B |
| 2024-06-30 | $43.38 | 56.8M | $2.46B | $84.52M | $64.62M | $2.44B |
| 2024-03-31 | $28.86 | 56.38M | $1.63B | $118.76M | $68.35M | $1.58B |
| 2023-12-31 | $22.27 | 55.9M | $1.24B | $88.2M | $72M | $1.23B |
| 2023-09-30 | $24.75 | 55.8M | $1.38B | $64.33M | $75.5M | $1.39B |
| 2023-06-30 | $28.32 | 55.5M | $1.57B | $84.75M | $78.95M | $1.57B |